1. World Health Organization. Novel Coronavirus First Situation Report: WHO 2019 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
2. Worldometer Coronavirus 2021. [Available from: https://www.worldometers.info/coronavirus/.
3. World Health Organization Novel Coronavirus Situation Reports WHO 2021 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/.
4. Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, et al. Community mitigation guidelines to prevent pandemic influenza—United States, 2017. MMWR Recomm Rep. 2017;66:1. https://doi.org/10.15585/mmwr.rr6601a1
5. Chakraborty I, Maity P. COVID-19 outbreak: Migration, effects on society, global environment and prevention. Sci Total Environ. 2020;728:138882. https://doi.org/10.1016/j.scitotenv.2020.138882
6. Alfano V, Ercolano S. The efficacy of lockdown against COVID-19: a cross-country panel analysis. Appl Health Econ Health Policy. 2020;18:509-17. https://doi.org/10.1007/s40258-020-00596-3
7. Vinceti M, Filippini T, Rothman KJ, Ferrari F, Goffi A, Maffeis G, et al. Lockdown timing and efficacy in controlling COVID-19 using mobile phone tracking. EClinicalMedicine. 2020;25:100457. https://doi.org/10.1016/j.eclinm.2020.100457
8. Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020;4:1303-12. https://doi.org/10.1038/s41562-020-01009-0
9. A C. Lockdowns don't work unless workers can afford to follow restrictions: The Guardian 2021 [Available from: https://www.theguardian.com/commentisfree/2021/jan/08/lockdowns-workers-restrictions-self-isolate.
10. Bhattacharyya I. Why India’s Lockdown Has Been a Spectacular Failure: The Wire 2020 [Available from: https://thewire.in/government/india-covid-19-lockdown-failure.
11. Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586:516-27. https://doi.org/10.1038/s41586-020-2798-3
12. Xia S, Duan K, Zhang Y, Zhao D, Zhang H, Xie Z, et al. Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes: interim analysis of 2 randomized clinical trials. JAMA. 2020;324:951-60. https://doi.org/10.1001/jama.2020.15543
13. Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467-78. https://doi.org/10.1016/S0140-6736(20)31604-4
14. Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. The Lancet. 2021;397:642-3. https://doi.org/10.1016/S0140-6736(21)00191-4
15. Silveira MM, Moreira GMSG, Mendonça M. DNA vaccines against COVID-19: Perspectives and challenges. Life Sci. 2021;267:118919. https://doi.org/10.1016/j.lfs.2020.118919
16. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report. N Engl J Med. 2020;383:1920-31. https://doi.org/10.1056/NEJMoa2022483
17. Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021;384:1412-23. https://doi.org/10.1056/NEJMoa2101765
18. Zhu F-C, Li Y-H, Guan X-H, Hou L-H, Wang W-J, Li J-X, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395:1845-54. https://doi.org/10.1016/S0140-6736(20)31208-3
19. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2020;384:403-16. https://doi.org/10.1056/NEJMoa2035389
20. Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review. Acad Radiol. 2021. https://doi.org/10.1016/j.acra.2021.04.007
21. World Health Organization. Coronavirus disease (COVID-19): Vaccines 2020 [Available from: https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey.
22. World Health Organization. WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: WHO 2020 [Available from: https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access.
23. Oku A, Oyo-Ita A, Glenton C, Fretheim A, Eteng G, Ames H, et al. Factors affecting the implementation of childhood vaccination communication strategies in Nigeria: a qualitative study. BMC Public Health. 2017;17:1-12. https://doi.org/10.1186/s12889-017-4020-6
24. Higher coverage attained through public participation: National Vaccination Days in Bolivia. EPI Newsl. 1985;7:4-6.
25. Itimi K, Dienye PO, Ordinioha B. Community participation and childhood immunization coverage: A comparative study of rural and urban communities of Bayelsa State, south-south Nigeria. Niger Med J. 2012;53:21-5. https://doi.org/10.4103/0300-1652.99826
26. El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and Attitudes Toward COVID-19 Vaccines: A Cross-Sectional Study from Jordan. PLoS One. 2021;23:16(4):e0250555. https://doi.org/10.1371/journal.pone.0250555
27. Inc. R. Sample size calculator 2021 [Available from: http://www.raosoft.com/samplesize.html.
28. Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020;38:7002-6. https://doi.org/10.1016/j.vaccine.2020.09.041
29. Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16:2204-14. https://doi.org/10.1080/21645515.2020.1790279
30. Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225-8. https://doi.org/10.1038/s41591-020-1124-9
31. Olagoke AA, Olagoke OO, Hughes AM. Intention to vaccinate against the novel 2019 coronavirus disease: The role of health locus of control and religiosity. J Relig Health. 2021;60:65-80. https://doi.org/10.1007/s10943-020-01090-9
32. Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. https://doi.org/10.1016/j.eclinm.2020.100495
33. Eguia H, Vinciarelli F, Bosque-Prous M, Kristensen T, Saigí-Rubió F. Spain’s Hesitation at the Gates of a COVID-19 Vaccine. Vaccines. 2021;9:170. https://doi.org/10.3390/vaccines9020170
34. Fonzo M, Bertoncello C, Cocchio S, Zanovello S, Bennici S, Baldovin T, et al. Health professionals as parents are not immune to vaccine hesitancy–an Italian national survey. Eur J Public Health. 2019;29:ckz186. 526.
35. Askarian M, Fu L, Taghrir MH, Borazjani R, Shayan Z, Taherifard E, et al. Factors Affecting Covid-19 Vaccination Intent Among Iranians: COVID-19 Vaccination Acceptance. 2020.
36. Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg Health Eur. 2021;1:100012. https://doi.org/10.1016/j.lanepe.2020.100012
37. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines. 2020;8:482. https://doi.org/10.3390/vaccines8030482
38. Tozzi AE, Gesualdo F, Romano M, Caione D. Parental attitude toward influenza A (H1N1) v vaccination in Italy. Vaccine. 2009;27. https://doi.org/10.1016/j.vaccine.2009.09.020
39. Vasilevska M, Ku J, Fisman DN. Factors associated with healthcare worker acceptance of vaccination: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2014;35:699-708. https://doi.org/10.1086/676427
40. Kornides ML, McRee A-L, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018;18:S37-S43. https://doi.org/10.1016/j.acap.2017.06.008